PRA Health Sciences, Inc. PRAH
$ 165.21
0.0%
PRA Health Sciences, Inc. Financial Statements 2011-2024 | PRAH
Annual Financial Statements PRA Health Sciences, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
7.87 B | 6.53 B | 6.72 B | 5.73 B | 3.44 B | 2.58 B | 1.12 B | - | - | - |
Shares |
63.8 M | 64.5 M | 64.1 M | 62.4 M | 60.8 M | 60 M | 42.9 M | - | - | - |
Net Income |
197 M | 243 M | 154 M | 86.9 M | 68.2 M | 81.8 M | -35.7 M | - | -2.71 M | - |
Revenue |
3.18 B | 3.07 B | 2.87 B | 2.26 B | 1.81 B | 1.61 B | 1.46 B | - | 700 M | - |
EBITDA |
416 M | 482 M | 429 M | 343 M | 277 M | 243 M | 153 M | - | 77.9 M | - |
Operating Expenses |
585 M | 510 M | 484 M | 400 M | 339 M | 324 M | 351 M | - | 191 M | - |
General and Administrative Expenses |
453 M | 395 M | 372 M | 322 M | 270 M | 246 M | - | - | - | - |
All numbers in USD currency